Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Masuhara, M.
Right arrow Articles by Shinozuka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuhara, M.
Right arrow Articles by Shinozuka, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

research-article

Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats

Masaaki Masuhara, Hisataka Ogasawara, Sikandar L. Katyal, Toshikazu Nakamura 1 and Hisashi Shinozuka 2

Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, PA 15261, USA
1Department of Biology, Faculty of Science, Kyushu University Fukuoka 812, Japan

2To whom correspondence should be addressed

A recent study from our laboratory demonstrated that cyclo-sporine (CsA), a prototype immunosuppressant, enhanced the growth of carcinogen-induced enzyme altered foci in rat liver, suggesting that CsA may stimulate development of hepato-cellular carcinomas. In the present study, we examined (i) whether CsA accelerates development of hepatocellular carcinomas in experimental animals, (ii) whether CsA stimulates the proliferation of resting hepatocyte in vivo and (iii) whether CsA modulates the production of growth factors implicated in liver cell growth, hepatocyte growth factor (HGF), transforming growth factor a (TGF{alpha}) and transforming growth factor ß1 (TGFßß1). Foci of hepatocytes, positive for glutathione S-transferase placental form were induced in male F344 rats by a single dose of diethylnitros-amine followed by 7 weeks promotion by a choline-deficient diet. The animals were then divided in two groups, and subsequent development of hepatocellular carcinomas was compared in rats fed a basal diet or a basal diet containing 0.015% CsA. Development of hepatocellular carcinomas was accelerated in the rats maintained on a CsA diet. Feeding a CsA diet as the sole treatment, for 2, 4 and 10 weeks induced significant increases in liver weight, and resulted also in an enhanced incorporation by hepatocytes of 5-bromo-2-deoxy-uridine. Serum levels of glutamate-oxaloacetate transferase, glutamate-pyruvate transferase and lactic dehydrogenase were not altered by feeding a CsA diet. Northern Blot analyses of the expression of HGF, TGF{alpha} and TGFß1 mRNAs in the liver showed similar patterns of expression between rats fed a basal diet and a CsA diet. The levels of HGF mRNA were not altered in the lungs and kidneys of rats fed a CsA diet. These results indicate that CsA stimulates rat liver cell proliferation in vivo without inducing liver cell necrosis, and that this effect may contribute to accelerated development of hepatocellular carcinomas in rats fed a CsA diet. As previously observed with BR 931, a hypolipidemic peroxisome proliferator, stimulation of liver cell growth by CsA did not entail changes in the production of HGF, TGF{alpha} or TGFß1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Domhan, M. Zeier, and A. Abdollahi
Immunosuppressive therapy and post-transplant malignancy
Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1097 - 1103.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Duque, M. Fresno, and M. A. Iniguez
Expression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells: INVOLVEMENT IN THE REGULATION OF CYCLOOXYGENASE-2
J. Biol. Chem., March 11, 2005; 280(10): 8686 - 8693.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
K L Hastings
Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models
Human and Experimental Toxicology, April 1, 2000; 19(4): 261 - 265.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
S. J. Provencher, C. Demers, M.-C. Bastien, J.-P. Villeneuve, and M. Gascon-Barré
Effect of Cyclosporine A on Cytochrome P-450-Mediated Drug Metabolism in the Partially Hepatectomized Rat
Drug Metab. Dispos., April 1, 1999; 27(4): 449 - 455.
[Abstract] [Full Text]


Home page
International Journal of ToxicologyHome page
H. C. Pitot
The Progression of Neoplasia, Cell Replication, and Electromagnetic Fields
International Journal of Toxicology, January 1, 1998; 17(3_suppl): 59 - 108.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.